Metabolic dysfunction-associated steatotic liver disease (MASLD) is increasingly recognised as a systemic disorder driven ...

Only one out of every five adults with cirrhosis in safety-net health systems receive guideline-concordant hepatocellular ...

Patients with very early or early-stage hepatocellular carcinoma have similar survival with external beam radiation as they ...

Microsoft customers worldwide can now discover and deploy RhythmX Pulse through Microsoft Marketplace, accessing trusted solutions that accelerate innovation and business transformation with unified ...

Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company ...

A cGMP-related CRL can delay approval despite substantial efficacy/safety evidence and often requires manufacturing remediation and reinspection rather than additional clinical trials. Phase III CARES ...

Special Hia Panel Proposed To Fast-track Scrutiny Of Development Projects ...

Perineural invasion may help refine risk assessment in intrahepatic bile duct cancer. Find out what this meta-analysis means ...

While housing activity remains near cyclical lows, we believe Builders FirstSource should be able to sustain this level of ...

Black Bear Value Fund, LP (the “Fund”) returned -3.6% in June and +1.5% YTD. The S&P 500 returned -1.0% in June and +10.2% ...

For decades, a diagnosis of fatty liver disease was met with a fairly standard, isolated piece of advice: "Watch your diet ...

Fluidx Medical Technology, Inc. announced results from a pivotal clinical trial evaluating the company’s GPX embolic device.